Becton Dickinson

  • Look to This Medical Equipment Leader For Consistent Growth

    By Matthew Frankel - August 17, 2013 | Tickers: BAX, BDX, MDT

    The health care sector can be daunting for some investors, and there are some good reasons for why many people won’t go near health care stocks. First, the health care laws have been changing constantly (how many times has Obamacare been changed?) and it is hard to say with any degree of certainty how the changing laws will affect these companies’ bottom lines. Also, when a lot of people more »

  • This Healthcare Stock Can Continue Its Rally

    By Piyush Arora - July 29, 2013 | Tickers: BAX, BDX, STJ

    Thanks to an expanding product portfolio, increasing healthcare spending, and explosive growth in the emerging markets, the healthcare industry has been growing at a stellar rate lately. Medical supplies and equipment providers are benefiting the most, as they serve the global healthcare industry. One of the most prominent beneficiaries has been Becton Dickinson (NYSE: BDX), which has recorded an appreciation of 45% over the last year. But, despite the recent more »

  • Billionaire Michael Price’s Long Term Stock Picks

    By Meena Krishnamsetty - July 21, 2013 | Tickers: BDX, C, GLF, MHFI, RUTH

    One of the most common objections to incorporating 13F filings into an investment process is that the information in these filings is a bit out of date; the most recent round of filings discloses many of a hedge fund’s or other major investor’s long equity positions as of the end of March. However, at Insider Monkey we’ve actually found that the most popular small cap stocks among more »

  • Is This Gloomy Warning a Telltale Sign for the Medical Devices Industry?

    By Ryan Guenette - July 17, 2013 | Tickers: BAX, BDX, ISRG, MDT

    On July 9, Intuitive Surgical (NASDAQ: ISRG) warned of second-quarter financial results coming in at disappointing levels, although the company does not officially report until July 18.

    The company stated that it expects sales to come in at $575 million for the second quarter, nearly 9% south of the consensus of Wall Street analysts. Year over year, growth is still anticipated to top 7%; however, it will be the first more »

  • How to Spot the Next Ten Bagger

    By Shmulik Karpf - July 16, 2013 | Tickers: A, BDX, RHHBY

    In his classic book, "Common Stocks And Uncommon Profits," Philip Fisher describes the attributes of a great investment, one that will return hundreds of percent in gains to its investors.

    One of his main principles to look for in a winning stock is how much the prospective company spends on research and development (R&D). He explains that the only way an investor can realistically expect consistent gains over ten more »

  • 3 Medical Instrument and Supply Companies You Don’t Want to Miss

    By Shweta Dubey - July 10, 2013 | Tickers: BAX, BDX, COV

    The U.S. is the world’s leading medical device manufacture. Becton Dickinson (NYSE: BDX), Baxter International (NYSE: BAX), Covidien (NYSE: COV) are amongst the top ten manufactures for medical devices. The U.S. medical device industry is expected to grow at CAGR 6.3% for the period of 2011-2018. The medical device market revenue is projected to increase from $102.1 billion in 2011 to $156.8 billion by more »

  • When Should Investors Buy This New Pharma Company?

    By Mike Thiessen - July 10, 2013 | Tickers: BDX, COV, MNK

    After nearly two years of waiting, Covidien (NYSE: COV) investors were finally treated to the latest in a long line of pharmaceutical and medical device spin-offs. As of July 1, 2013, Dublin-based Covidien and St. Louis-based Mallinckrodt Pharmaceuticals (NYSE: MNK) had formally split into separate companies that traded independently of one another. Although the companies have thus far experienced divergent share-price performance, this development has been welcomed by investors on more »

  • This Diagnostics Business Could be A Good Play on Shareholder Activism

    By Anh HOANG - June 25, 2013 | Tickers: ALR, BDX, HWAY

    Since the beginning of the year, Alere (NYSE: ALR) has experienced a significant gain of nearly 34.3%, handily beating the S&P 500’s return of only 11.7%. Moreover, it is also the target of recent shareholder activism by one of its largest shareholders, Coppersmith Capital Management. Coppersmith owns around a 5.8% stake in the company, and is urging the company to divest three of its businesses more »

  • Michael Price Is Bullish on This Drug Manufacturer

    By Anh HOANG - June 24, 2013 | Tickers: BAX, BDX, HSP

    Editor's Note:The initial article stated Hospira closed their largest plant due to FDA actions. This is incorrect; Hospira shut their plant for scheduled maintenance. This version has been corrected and Motley Fool apologizes for the error.

    At the London Value Investor Conference, famous value investor Michael Price pitched Hospira (NYSE: HSP) as one of his favorite stocks. As of March, Price owned 400,000 Hospira shares. Hospira seems more »

  • A Discounted Medical Equipment Play

    By Matthew Frankel - June 19, 2013 | Tickers: BDX, MDT, STJ

    When it comes to investing in the healthcare sector, there is lots of money to be made if investors choose wisely. Factors such as the current healthcare laws, which require a greater number of people to be insured, as well as an aging population should translate to higher spending on medical care over the next several years and beyond. My favorite way to play the sector over the long-term is more »

  • Don’t Believe the Hype about Medical Device Stocks

    By Jonathan Yates - June 9, 2013 | Tickers: BAX, BDX, BSX

    A major loser in the Affordable Health Care Act, or Obamacare, was supposed to be the medical device and equipment industry, which ranges from blue chip heavyweights with wide product offerings such as Boston Scientific (NYSE: BSX), Becton,Dickinson & Co. (NYSE: BDX), and Baxter International (NYSE: BAX) to specialized small caps such as PLC Systems (NASDAQ: PLCSF). The main feature of Obamacare that was expected to damage the sector the more »

  • Billionaire Richard Chilton’s Bullish First Quarter Bets

    By Meena Krishnamsetty - May 31, 2013 | Tickers: BUD, BDX, MHFI, WFC

    Billionaire Richard Chilton’s Chilton Investment Company, with some $9 billion in assets under management, recently filed its 13F, presenting this hedge fund’s portfolio of holdings at the end of the first quarter. Chilton’s portfolio at the end of the quarter was fairly diversified and included a number of stocks that offer respectable dividend yields.

    Chilton is an avid value investor focused on companies boasting organic sales growth more »

  • My Favorite Metric

    By Steve Van - May 21, 2013 | Tickers: DDD, BDX, KO, GPC, TUP

    In the 1960’s there was a television sit-com called “My Favorite Martian” with the premise of a Martian who has somehow entered the life of an Earthling. In the course of the show, the Martian’s unique and often comic perspective on Earthly life leads his human friend to see his everyday world in fresh ways. In a similar vein, “My Favorite Metric” might help human investors to see more »

  • Does the Healthcare Industry mean Stability?

    By tarun bachhawat - May 14, 2013 | Tickers: BDX, COV, NVO

    A leading medical technology company, Becton, Dickinson and Company's (NYSE: BDX) earnings were better than expected. It is one of the few medical companies that is able to deliver organic growth in a challenged healthcare industry. 

    A decent quarter
     
    Becton Dickinson reported revenue of $2 billion for the quarter and profit of $275.6 million, beating Wall Street's estimate by $0.04 per share. Revenue from sales in more »
  • The Best In An Expensive Sector

    By Matthew Frankel - May 13, 2013 | Tickers: BAX, BDX, MDT

    Medtronic Inc. (NYSE: MDT) is one of the leading manufacturers of equipment for the health care industry.  In fact, the company has a leading market share in several categories, including pacemakers, defibrillators, and diabetes products just to name a few.  The company has grown its revenues tremendously over the past decade (see below), with sales up each and every year, including the entire tumultuous 2008-2010 period.  How many other health more »

  • This Large Cap Manufacturer Is a Steal Below Liquidation Value

    By Ted Cooper - May 7, 2013 | Tickers: BDX, GLW, TEL

    It is not often that you come across a large cap stock trading below liquidation value, but that is exactly the case with Corning (NYSE: GLW). The company sells right at, or slightly below, tangible book value, which is a rough approximation of what shareholders would receive if the company decided to close its doors and sell its assets today.

    Although Corning is unlikely to liquidate in the near future more »

  • This Medical Company Is Not Cheap

    By Anh HOANG - May 2, 2013 | Tickers: BDX, BCR, COV

    Recently, Covidien (NYSE: COV) witnessed a significant decline of nearly 7% after it announced sluggish second-quarter earnings. Even after the drop, Covidien’s share price has gained more than 7.3% since the beginning of the year. The company is currently in the portfolios of several famous investors including Ray Dalio, Steven Cohen, and Paul Tudor Jones. Should we consider a recent drop in its share price as an investment more »

  • Dividend Aristocrats That Sweep You Off Your Feet

    By AnnaLisa Kraft - May 1, 2013 | Tickers: ADM, BDX, DOV, CB, WAG

    In an effort to educate the 34% of women who know nothing of investing, Yahoo! Finance has a saucy video for the ladies featuring three barechested studs representing stocks, bonds, and mutual funds. Why Mr. Stocks is the skinniest, I'm sure I don't know, because how much more appealing would Mr. Stocks be if they mentioned how he bulks up when you add dividends?

    Maybe they should have more »

  • A Look at Fundamentals Ahead of Upcoming Earnings

    By John Macris - May 1, 2013 | Tickers: AIG, BDX, K

    First quarter earnings season is well underway, and a clear trend has yet to emerge among the various reports so far. Companies that have a majority exposure to the United States have fared well, while multinationals with European exposure have provided a lukewarm outlook.

    Market participants also received significant economic data within the last week. Gross domestic product rose at a 2.5% pace during Q1, driven in large part more »

  • Trounce the Market With This Diabetes Care Company

    By Greg Williamson - April 28, 2013 | Tickers: BDX, LLY, NVO, SNY

    Diabetes currently affects an estimated 350 million people worldwide. This number is projected to grow to well over 500 million people by 2030.

    Diabetes is a very serious disease that results from high levels of glucose caused by the body not being able to effectively produce insulin (type 1 diabetes) or use insulin (type 2 diabetes). Diabetes is a leading cause of a wide variety of complications including kidney failure more »

  • Page 1 of 3